- Medical - Diagnostics & Research
- Healthcare
-
10.04
EPS
-
33.75
P/E
-
20.1B
MARKET CAP
-
0.00%
DIV YIELD
Company Overview
34 MAPLE ST,MILFORD MA 01757,5084782000
CEO
Dr. Udit Batra Ph.D.
Employess
7900
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Website
https://www.waters.com
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
Next Earnings Date
Nov. 5, 2024
Ex Dividends date
--
Dividend Date
--
YTD Performance
3.26%
Fiscal Year End
12-31
IPO Date
1995-11-17
Growth Rates
(avg. rate of change) | 10 years | 5 years | 3 years | 1 year |
---|---|---|---|---|
Sales/Revenue | 4.50% | 4.09% | 7.72% | -0.52% |
EPS | 7.51% | 7.11% | 8.97% | -7.88% |
Equity | -4.18% | -6.00% | 70.49% | 128.02% |
Cash | -1.09% | -13.08% | -3.28% | -17.78% |
Return On Capital (ROIC) | 19.24% | 28.62% | 30.68% | 20.83% |
Debt
year (millions) | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Short Term Debt | 77.8 | 76.4 | 27.9 | 178 | 1,680 |
Long Term Debt | 2,310 | 1,570 | 1,510 | 1,360 | 1,650 |
LT Finance Leases | 58.9 | 88.5 | 87.5 | 96 | 94 |
Shares Outstanding | 59.1 | 60 | 61.6 | 62.1 | 67.6 |
Market Cap | 19,400 | 20,500 | 22,900 | 15,400 | 15,800 |
Price
News
Deciphering Waters (WAT) International Revenue Trends
1 monthExplore how Waters' (WAT) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
zacks.comWaters (WAT) Q2 Earnings & Sales Beat Estimates, Fall Y/Y
2 monthsWaters' (WAT) second-quarter results are hurt by weak end-market momentum and softness in Asia, Americas and Europe.
zacks.comWaters Corporation (WAT) Q2 2024 Earnings Call Transcript
2 monthsWaters Corporation (NYSE:WAT ) Q2 2024 Earnings Conference Call July 31, 2024 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President and Chief Executive Officer Amol Chaubal - Senior Vice President and Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Dan Brennan - TD Cowen Tycho Peterson - Jefferies Rachel Vatnsdal - JPMorgan Dan Arias - Stifel Jack Meehan - Nephron Research Catherine Schulte - Baird Operator Good morning. Welcome to the Waters Corporation Second Quarter 2024 Financial Results Conference Call.
seekingalpha.comCompared to Estimates, Waters (WAT) Q2 Earnings: A Look at Key Metrics
2 monthsAlthough the revenue and EPS for Waters (WAT) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zacks.comWaters (WAT) Q2 Earnings and Revenues Top Estimates
2 monthsWaters (WAT) came out with quarterly earnings of $2.63 per share, beating the Zacks Consensus Estimate of $2.55 per share. This compares to earnings of $2.80 per share a year ago.
zacks.comWaters Corporation (NYSE: WAT) Reports Second Quarter 2024 Financial Results
2 monthsHighlights Sales of $709 million exceeded guidance on a reported basis, declined 4% as reported and 4% in organic constant currency GAAP EPS of $2.40; earnings exceeded guidance with non-GAAP EPS of $2.63, led by strong operational performance Beat driven by better-than-expected performance in China, as well as higher-than-expected M&A contribution to overall sales from Wyatt Ex-China organic constant currency sales growth as expected across Pharma, Industrial, and Academic & Government end markets Full-year outlook reflects the potential for a more gradual market improvement in the second half of the year than previously anticipated Second Quarter 2024 MILFORD, Mass. , July 31, 2024 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced its financial results for the second quarter of 2024.
prnewswire.comWaters (WAT) to Report Q2 Earnings: What's in the Offing?
2 monthsWaters' (WAT) second-quarter 2024 results are likely to reflect strength in the large molecule and PFAS testing markets amid weakening demand in China.
zacks.comAnalysts Estimate Waters (WAT) to Report a Decline in Earnings: What to Look Out for
2 monthsWaters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zacks.comWaters New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody Drugs
2 monthsNews Summary: Reduces sample volume requirements by 25x through use of advanced microfluidic technologies while increasing throughput up to 24x compared with competitor capillary DSC technologiesi. Streamlines thermal stability testing of biologics using disposable microfluidic chips (MFCs) enabling analysis under actual high-concentration drug dosing and use conditions.
prnewswire.comWill Carnival Stock Continue to Sail in Smooth Waters?
2 monthsBookings are at record highs. Carnival has managed to service and reduce its massive debt.
fool.comWaters Corporation Schedules Second Quarter 2024 Earnings Conference Call
3 monthsMILFORD, Mass. , July 2, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2024 financial results conference call live on Wednesday, July 31st, 2024 at 8:00 a.m.
prnewswire.comEurofins Scientific's stock drops on allegations from short-seller Muddy Waters
3 monthsEurofins Scientific shares plunged on Monday after Muddy Waters Research said in a report it had started shorting the laboratory-services company, alleging founder and Chief Executive Gilles Martin has spent decades “covertly enriching” himself through improper real-estate deals.
marketwatch.com